Disclaimer
Spectral Genomics provides information for educational and research purposes. Please read this page before relying on anything on this site.
Not medical advice
Nothing on this site is medical advice, and nothing here should be used to diagnose or treat any condition or to decide whether to take, stop, or enroll in a trial of any medicine. Experimental drugs have not been approved and their benefits and risks are not fully known. Talk to a qualified healthcare professional about any medical decision.
Not investment advice
Spectral Genomics is not a registered investment adviser or broker-dealer. Nothing on this site is a recommendation to buy, sell, or hold any security. Information about companies and their drug programs is provided for research and education only.
About probability estimates
Probability estimates and historical benchmarks describe the statistical likelihood of drug development outcomes. They are uncertain by nature, and individual outcomes can and do differ from them. A drug’s approval probability is not a forecast of a company’s share price or of any investment return, and regulatory success does not guarantee commercial success.
Accuracy and completeness
We work to keep information accurate and current, and we cite our sources so you can check them. Public data sources can contain errors, delays, and gaps, and our records may not reflect the most recent developments. Always consult the original sources before making a decision.
Company-reported information
Some information on this site comes from companies’ own disclosures, such as press releases and investor presentations. We label it as company-reported. It has not necessarily been independently verified or peer reviewed.